LDR | |
01168nam a2200337 a 4500 |
001 |
|
002589890 |
003 |
|
MiAaHDL |
005 |
|
20210817000000.0 |
006 |
|
m d |
007 |
|
cr bn ---auaua |
008 |
|
930119s1992 gw a b 000 0 eng c |
010 |
⊔ |
⊔ |
‡a92002198
|
020 |
⊔ |
⊔ |
‡a0387553010
‡q(New York : alk. paper)
|
020 |
⊔ |
⊔ |
‡a3540553010
‡q(Berlin : alk. paper)
|
035 |
⊔ |
⊔ |
‡a(MiU)990025898900106381
|
035 |
⊔ |
⊔ |
‡asdr-miu.990025898900106381
|
035 |
⊔ |
⊔ |
‡a(OCoLC)25413010
|
035 |
⊔ |
⊔ |
‡z(MiU)Aleph002589890
|
040 |
⊔ |
⊔ |
‡aDNLM/DLC
‡cDLC
‡dNLM
‡dEYM
|
050 |
0 |
0 |
‡aRC268
‡b.C655 1992
|
060 |
0 |
⊔ |
‡aQZ 267
‡bC7633 1992
|
082 |
0 |
0 |
‡a616.99/405
‡220
|
245 |
0 |
0 |
‡aControl of growth factors and prevention of cancer /
‡cMichael B. Sporn (ed.).
|
260 |
⊔ |
⊔ |
‡aBerlin ;
‡aNew York :
‡bSpringer-Verlag,
‡cc1992.
|
300 |
⊔ |
⊔ |
‡a74 p. :
‡bill. ;
‡c29 cm.
|
490 |
0 |
⊔ |
‡aMonographs / European School of Oncology
|
504 |
⊔ |
⊔ |
‡aIncludes bibliographical references.
|
538 |
⊔ |
⊔ |
‡aMode of access: Internet.
|
650 |
⊔ |
2 |
‡aNeoplasms
‡xprevention & control.
|
650 |
⊔ |
2 |
‡aGrowth Substances
‡xphysiology.
|
650 |
⊔ |
0 |
‡aCancer
‡xHormone therapy.
|
650 |
⊔ |
0 |
‡aRetinoids
‡xTherapeutic use.
|
650 |
⊔ |
0 |
‡aGrowth factors.
|
650 |
⊔ |
0 |
‡aCancer
‡xPrevention.
|
700 |
1 |
⊔ |
‡aSporn, Michael B.
|
CID |
⊔ |
⊔ |
‡a002589890
|
DAT |
0 |
⊔ |
‡a19930119000000.0
‡b20210817000000.0
|
DAT |
1 |
⊔ |
‡a20210927060711.0
‡b2023-06-25T17:58:53Z
|
CAT |
⊔ |
⊔ |
‡aSDR-MIU
‡dALMA
‡lprepare.pl-004-008
|
FMT |
⊔ |
⊔ |
‡aBK
|
HOL |
⊔ |
⊔ |
‡0sdr-miu.990025898900106381
‡aMiU
‡bSDR
‡cMIU
‡pmdp.39015028475591
‡sMIU
‡1990025898900106381
|
974 |
⊔ |
⊔ |
‡bMIU
‡cMIU
‡d20230625
‡sgoogle
‡umdp.39015028475591
‡y1992
‡ric
‡qbib
‡tnon-US bib date1 >= 1929
|